Latest debt-to-equity ratio
Candel Therapeutics Debt-to-equity ratio
Direct answer
Candel Therapeutics's debt-to-equity ratio is 39.26%.
The verified market snapshot reports 39.26%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 22, 2026.
Get free Candel Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 39.26%
Explore related company data
View Candel Therapeutics's market capitalizationView Candel Therapeutics's price-to-book ratioView Candel Therapeutics's return on equityView Candel Therapeutics's dividend yieldView Candel Therapeutics's 52-week price rangeView Candel Therapeutics's profit marginView all Candel Therapeutics key metricsReturn to Candel Therapeutics profile